| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zebrafish | 353 | 2024 | 3007 | 29.110 |
Why?
|
| Zebrafish Proteins | 115 | 2024 | 1015 | 12.410 |
Why?
|
| Hematopoietic Stem Cells | 120 | 2024 | 3394 | 11.600 |
Why?
|
| Hematopoiesis | 118 | 2024 | 2049 | 11.050 |
Why?
|
| Embryo, Nonmammalian | 84 | 2022 | 905 | 7.100 |
Why?
|
| Gene Expression Regulation, Developmental | 96 | 2024 | 3608 | 4.560 |
Why?
|
| Melanocytes | 22 | 2021 | 509 | 4.390 |
Why?
|
| Melanoma | 39 | 2024 | 5697 | 4.210 |
Why?
|
| Neural Crest | 12 | 2021 | 279 | 3.250 |
Why?
|
| Animals, Genetically Modified | 69 | 2024 | 1557 | 3.220 |
Why?
|
| Erythropoiesis | 28 | 2021 | 684 | 3.210 |
Why?
|
| Animals | 476 | 2024 | 168201 | 3.120 |
Why?
|
| Transcription Factors | 73 | 2024 | 12116 | 2.740 |
Why?
|
| Stem Cell Niche | 11 | 2023 | 344 | 2.670 |
Why?
|
| Cell Lineage | 36 | 2021 | 2554 | 2.460 |
Why?
|
| Drug Evaluation, Preclinical | 13 | 2021 | 1333 | 2.300 |
Why?
|
| Dinoprostone | 10 | 2023 | 597 | 2.160 |
Why?
|
| Disease Models, Animal | 52 | 2021 | 18221 | 2.130 |
Why?
|
| Hematologic Diseases | 11 | 2020 | 496 | 2.050 |
Why?
|
| Embryonic Development | 19 | 2020 | 721 | 1.960 |
Why?
|
| Erythrocytes | 22 | 2021 | 2410 | 1.810 |
Why?
|
| Signal Transduction | 65 | 2024 | 23416 | 1.770 |
Why?
|
| Cell Differentiation | 73 | 2024 | 11514 | 1.770 |
Why?
|
| DNA-Binding Proteins | 60 | 2020 | 9586 | 1.720 |
Why?
|
| Stem Cells | 28 | 2021 | 3516 | 1.660 |
Why?
|
| Calreticulin | 2 | 2024 | 114 | 1.640 |
Why?
|
| Mesoderm | 26 | 2017 | 674 | 1.590 |
Why?
|
| Mutation | 87 | 2023 | 30016 | 1.580 |
Why?
|
| Anemia, Diamond-Blackfan | 7 | 2020 | 138 | 1.580 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 21 | 2023 | 5672 | 1.490 |
Why?
|
| Proto-Oncogene Proteins c-myb | 7 | 2018 | 78 | 1.490 |
Why?
|
| Erythroid Cells | 12 | 2019 | 238 | 1.450 |
Why?
|
| Models, Animal | 13 | 2019 | 2109 | 1.440 |
Why?
|
| Genes, ras | 5 | 2018 | 654 | 1.390 |
Why?
|
| Gene Expression Regulation | 30 | 2023 | 11874 | 1.390 |
Why?
|
| Skin Neoplasms | 11 | 2023 | 5812 | 1.360 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 9 | 2020 | 358 | 1.340 |
Why?
|
| Myeloid Cells | 8 | 2021 | 823 | 1.320 |
Why?
|
| Cell Movement | 23 | 2021 | 5200 | 1.300 |
Why?
|
| Cloning, Molecular | 43 | 2012 | 4172 | 1.300 |
Why?
|
| Small Molecule Libraries | 6 | 2016 | 733 | 1.300 |
Why?
|
| Drug Discovery | 6 | 2021 | 1051 | 1.300 |
Why?
|
| Homeodomain Proteins | 19 | 2013 | 2413 | 1.290 |
Why?
|
| Hematopoietic System | 9 | 2013 | 110 | 1.290 |
Why?
|
| Regeneration | 10 | 2024 | 1505 | 1.240 |
Why?
|
| Blastomeres | 3 | 2024 | 29 | 1.230 |
Why?
|
| GATA1 Transcription Factor | 23 | 2019 | 296 | 1.190 |
Why?
|
| Genes, Reporter | 10 | 2024 | 1525 | 1.170 |
Why?
|
| Bone Morphogenetic Proteins | 15 | 2015 | 841 | 1.160 |
Why?
|
| Transcription, Genetic | 28 | 2024 | 7583 | 1.150 |
Why?
|
| Proto-Oncogene Proteins | 30 | 2022 | 4512 | 1.140 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 3 | 2021 | 174 | 1.140 |
Why?
|
| Endothelium | 6 | 2019 | 764 | 1.110 |
Why?
|
| Tumor Suppressor Protein p53 | 15 | 2021 | 2917 | 1.100 |
Why?
|
| Developmental Biology | 4 | 2019 | 79 | 1.060 |
Why?
|
| In Situ Hybridization | 40 | 2017 | 1900 | 1.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 19 | 2024 | 8542 | 1.030 |
Why?
|
| Microinjections | 9 | 2012 | 321 | 1.010 |
Why?
|
| Hemangioblasts | 4 | 2018 | 28 | 1.010 |
Why?
|
| Muscle Development | 5 | 2023 | 259 | 1.010 |
Why?
|
| Blood Cells | 6 | 2021 | 305 | 1.000 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 3 | 2023 | 629 | 0.990 |
Why?
|
| Molecular Sequence Data | 87 | 2014 | 17629 | 0.960 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 6 | 2017 | 51 | 0.960 |
Why?
|
| Xenopus Proteins | 12 | 2021 | 434 | 0.940 |
Why?
|
| High-Throughput Screening Assays | 5 | 2021 | 933 | 0.940 |
Why?
|
| Wnt Proteins | 6 | 2012 | 718 | 0.940 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2020 | 682 | 0.940 |
Why?
|
| Tretinoin | 3 | 2021 | 519 | 0.940 |
Why?
|
| Myelopoiesis | 8 | 2021 | 134 | 0.920 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2024 | 410 | 0.910 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2024 | 97 | 0.910 |
Why?
|
| Macrophages | 9 | 2024 | 5758 | 0.900 |
Why?
|
| Disease | 3 | 2022 | 670 | 0.890 |
Why?
|
| Genes, Homeobox | 13 | 2014 | 286 | 0.890 |
Why?
|
| Satellite Cells, Skeletal Muscle | 2 | 2023 | 126 | 0.890 |
Why?
|
| beta 2-Microglobulin | 1 | 2024 | 328 | 0.880 |
Why?
|
| DEAD-box RNA Helicases | 4 | 2020 | 384 | 0.880 |
Why?
|
| Colorimetry | 1 | 2024 | 150 | 0.870 |
Why?
|
| Proto-Oncogene Proteins B-raf | 10 | 2021 | 2057 | 0.870 |
Why?
|
| RNA, Nuclear | 1 | 2023 | 29 | 0.860 |
Why?
|
| Embryonic Stem Cells | 12 | 2017 | 1262 | 0.860 |
Why?
|
| Embryo, Mammalian | 16 | 2018 | 1670 | 0.850 |
Why?
|
| Chromosome Mapping | 27 | 2011 | 4611 | 0.850 |
Why?
|
| Trans-Activators | 21 | 2018 | 2852 | 0.840 |
Why?
|
| Mice | 126 | 2024 | 81368 | 0.840 |
Why?
|
| Blood Vessels | 10 | 2016 | 1113 | 0.830 |
Why?
|
| Cell Tracking | 5 | 2018 | 139 | 0.830 |
Why?
|
| Stress, Physiological | 5 | 2021 | 1403 | 0.820 |
Why?
|
| Globins | 7 | 2017 | 405 | 0.810 |
Why?
|
| Genes, Suppressor | 2 | 2013 | 47 | 0.810 |
Why?
|
| Histones | 11 | 2023 | 2577 | 0.810 |
Why?
|
| Amino Acid Sequence | 65 | 2018 | 13441 | 0.800 |
Why?
|
| Integrases | 4 | 2013 | 518 | 0.800 |
Why?
|
| CDC2 Protein Kinase | 1 | 2023 | 213 | 0.800 |
Why?
|
| Cell Proliferation | 27 | 2024 | 10432 | 0.790 |
Why?
|
| Toxicity Tests | 3 | 2019 | 114 | 0.780 |
Why?
|
| Neoplasms | 18 | 2020 | 22131 | 0.780 |
Why?
|
| Genetic Engineering | 4 | 2016 | 931 | 0.770 |
Why?
|
| Nucleotides | 2 | 2021 | 453 | 0.770 |
Why?
|
| Cell Communication | 6 | 2022 | 1654 | 0.770 |
Why?
|
| Cooperative Behavior | 2 | 2021 | 1504 | 0.770 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2022 | 132 | 0.760 |
Why?
|
| Reproduction | 3 | 2022 | 645 | 0.760 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2022 | 70 | 0.760 |
Why?
|
| Iron | 10 | 2018 | 1790 | 0.750 |
Why?
|
| GATA2 Transcription Factor | 13 | 2021 | 158 | 0.750 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2021 | 5304 | 0.740 |
Why?
|
| Xenopus | 13 | 2006 | 711 | 0.740 |
Why?
|
| RNA Stability | 1 | 2023 | 320 | 0.730 |
Why?
|
| Mitochondria | 6 | 2021 | 3619 | 0.730 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 15 | 2001 | 638 | 0.730 |
Why?
|
| Genes, p53 | 6 | 2021 | 712 | 0.730 |
Why?
|
| Carcinogens | 1 | 2023 | 452 | 0.730 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2021 | 47 | 0.730 |
Why?
|
| Transgenes | 9 | 2016 | 1008 | 0.720 |
Why?
|
| Humans | 243 | 2024 | 760617 | 0.720 |
Why?
|
| Endoderm | 6 | 2012 | 160 | 0.720 |
Why?
|
| Rhabdomyosarcoma | 3 | 2013 | 358 | 0.710 |
Why?
|
| Receptors, Notch | 7 | 2024 | 743 | 0.710 |
Why?
|
| Embryology | 1 | 2020 | 30 | 0.700 |
Why?
|
| Positive Transcriptional Elongation Factor B | 2 | 2019 | 42 | 0.700 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2020 | 638 | 0.690 |
Why?
|
| Cation Transport Proteins | 7 | 2008 | 327 | 0.690 |
Why?
|
| Gene Transfer Techniques | 4 | 2013 | 1202 | 0.690 |
Why?
|
| Endothelium, Vascular | 11 | 2018 | 4433 | 0.690 |
Why?
|
| Cell Cycle | 12 | 2016 | 2930 | 0.680 |
Why?
|
| MAP Kinase Kinase 4 | 11 | 2001 | 146 | 0.680 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2020 | 2821 | 0.680 |
Why?
|
| Endothelial Cells | 12 | 2023 | 3548 | 0.670 |
Why?
|
| Carcinoma, Adenoid Cystic | 2 | 2021 | 262 | 0.670 |
Why?
|
| Pluripotent Stem Cells | 7 | 2024 | 796 | 0.670 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 2 | 2013 | 99 | 0.670 |
Why?
|
| Phenotype | 34 | 2020 | 16571 | 0.660 |
Why?
|
| Nucleosomes | 1 | 2023 | 487 | 0.660 |
Why?
|
| Green Fluorescent Proteins | 17 | 2024 | 2063 | 0.650 |
Why?
|
| Mutagenesis | 13 | 2022 | 1230 | 0.650 |
Why?
|
| Thymus Gland | 9 | 2022 | 1243 | 0.650 |
Why?
|
| Apoptosis | 24 | 2022 | 9476 | 0.640 |
Why?
|
| Leukemia, Myeloid | 3 | 2021 | 693 | 0.640 |
Why?
|
| Laboratories | 1 | 2022 | 458 | 0.640 |
Why?
|
| Stem Cell Transplantation | 6 | 2023 | 1600 | 0.640 |
Why?
|
| Genetic Testing | 9 | 2016 | 3533 | 0.630 |
Why?
|
| Ultraviolet Rays | 6 | 2021 | 1079 | 0.630 |
Why?
|
| Promoter Regions, Genetic | 21 | 2023 | 5780 | 0.630 |
Why?
|
| Sequence Homology, Amino Acid | 32 | 2008 | 2747 | 0.630 |
Why?
|
| Phagocytosis | 1 | 2024 | 1526 | 0.620 |
Why?
|
| Gene Targeting | 4 | 2016 | 837 | 0.620 |
Why?
|
| Cell Cycle Proteins | 6 | 2018 | 3447 | 0.610 |
Why?
|
| Publishing | 2 | 2021 | 832 | 0.610 |
Why?
|
| Oxylipins | 1 | 2018 | 53 | 0.610 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 23 | 2005 | 195 | 0.600 |
Why?
|
| Neovascularization, Physiologic | 10 | 2018 | 1349 | 0.600 |
Why?
|
| Cytological Techniques | 2 | 2010 | 218 | 0.590 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2017 | 2456 | 0.590 |
Why?
|
| Mitosis | 8 | 2009 | 1187 | 0.590 |
Why?
|
| Protein Kinases | 14 | 2015 | 1606 | 0.580 |
Why?
|
| Liver Regeneration | 4 | 2019 | 213 | 0.580 |
Why?
|
| Flow Cytometry | 17 | 2017 | 5863 | 0.580 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2017 | 47 | 0.570 |
Why?
|
| Mitochondrial Diseases | 1 | 2021 | 343 | 0.570 |
Why?
|
| Bone Marrow | 8 | 2016 | 2909 | 0.570 |
Why?
|
| ras Proteins | 5 | 2017 | 1054 | 0.570 |
Why?
|
| Gene Deletion | 5 | 2021 | 2661 | 0.560 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 12 | 2016 | 1133 | 0.560 |
Why?
|
| Nodal Signaling Ligands | 2 | 2017 | 12 | 0.560 |
Why?
|
| Fisheries | 1 | 2017 | 48 | 0.560 |
Why?
|
| Cell Culture Techniques | 5 | 2018 | 1662 | 0.550 |
Why?
|
| Melanoma, Experimental | 3 | 2018 | 561 | 0.540 |
Why?
|
| DNA, Complementary | 27 | 2008 | 1989 | 0.540 |
Why?
|
| Multipotent Stem Cells | 4 | 2021 | 200 | 0.540 |
Why?
|
| Gene Expression | 22 | 2019 | 7568 | 0.540 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2016 | 717 | 0.540 |
Why?
|
| Fish Diseases | 5 | 2019 | 37 | 0.540 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 1483 | 0.540 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2019 | 1250 | 0.530 |
Why?
|
| Evolution, Molecular | 15 | 2020 | 1880 | 0.530 |
Why?
|
| Behavior, Animal | 3 | 2016 | 1872 | 0.530 |
Why?
|
| Housing, Animal | 1 | 2016 | 47 | 0.520 |
Why?
|
| Base Sequence | 47 | 2019 | 12421 | 0.520 |
Why?
|
| Metalloproteins | 4 | 2005 | 101 | 0.520 |
Why?
|
| Interdisciplinary Studies | 1 | 2016 | 86 | 0.520 |
Why?
|
| Pigmentation | 4 | 2011 | 144 | 0.520 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2019 | 852 | 0.520 |
Why?
|
| Cell Line, Tumor | 17 | 2024 | 16967 | 0.520 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2020 | 1650 | 0.510 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 14 | 1999 | 489 | 0.510 |
Why?
|
| Erythropoietin | 11 | 2018 | 719 | 0.510 |
Why?
|
| Cadherins | 4 | 2015 | 901 | 0.500 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2015 | 64 | 0.500 |
Why?
|
| Ribosomal Proteins | 3 | 2014 | 370 | 0.500 |
Why?
|
| Aorta | 6 | 2024 | 2041 | 0.500 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2015 | 34 | 0.500 |
Why?
|
| Biological Evolution | 6 | 2018 | 1070 | 0.490 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2021 | 2895 | 0.490 |
Why?
|
| Receptors, Progesterone | 1 | 2020 | 1129 | 0.490 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2015 | 68 | 0.490 |
Why?
|
| Transplantation | 1 | 2016 | 219 | 0.480 |
Why?
|
| Color | 1 | 2016 | 299 | 0.480 |
Why?
|
| Epigenesis, Genetic | 6 | 2021 | 3794 | 0.480 |
Why?
|
| Neoplasm Transplantation | 8 | 2018 | 2010 | 0.480 |
Why?
|
| Transduction, Genetic | 2 | 2017 | 901 | 0.480 |
Why?
|
| Gene Knockout Techniques | 4 | 2019 | 801 | 0.470 |
Why?
|
| Angiopoietins | 1 | 2015 | 85 | 0.470 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2018 | 304 | 0.470 |
Why?
|
| Retroviridae | 1 | 2017 | 851 | 0.470 |
Why?
|
| Larva | 7 | 2022 | 508 | 0.470 |
Why?
|
| Biomedical Research | 3 | 2020 | 3426 | 0.470 |
Why?
|
| Genes | 11 | 2013 | 1823 | 0.470 |
Why?
|
| Blood | 2 | 2016 | 596 | 0.460 |
Why?
|
| Lentivirus | 1 | 2017 | 507 | 0.460 |
Why?
|
| Awards and Prizes | 1 | 2018 | 360 | 0.460 |
Why?
|
| Luminescent Proteins | 9 | 2015 | 836 | 0.460 |
Why?
|
| Repressor Proteins | 10 | 2021 | 2985 | 0.450 |
Why?
|
| Enhancer Elements, Genetic | 7 | 2024 | 1360 | 0.450 |
Why?
|
| RNA-Binding Proteins | 5 | 2016 | 1890 | 0.450 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2017 | 693 | 0.440 |
Why?
|
| Cell Line | 39 | 2021 | 15576 | 0.440 |
Why?
|
| Gene Knockdown Techniques | 11 | 2018 | 1608 | 0.440 |
Why?
|
| Genetic Vectors | 6 | 2017 | 3392 | 0.440 |
Why?
|
| Periodicals as Topic | 4 | 2019 | 1463 | 0.440 |
Why?
|
| Liver | 13 | 2019 | 7512 | 0.440 |
Why?
|
| Lymphoid Tissue | 4 | 2004 | 445 | 0.430 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2018 | 2872 | 0.430 |
Why?
|
| Endothelial Growth Factors | 4 | 2003 | 673 | 0.430 |
Why?
|
| Phylogeny | 15 | 2023 | 2806 | 0.420 |
Why?
|
| Kidney | 20 | 2018 | 7045 | 0.420 |
Why?
|
| Gene Expression Profiling | 24 | 2016 | 9417 | 0.420 |
Why?
|
| Oncogenes | 5 | 2020 | 1221 | 0.420 |
Why?
|
| Chromosomes | 6 | 2013 | 578 | 0.410 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 3593 | 0.410 |
Why?
|
| Erythroid Precursor Cells | 8 | 2018 | 212 | 0.410 |
Why?
|
| Blastula | 4 | 2018 | 15 | 0.410 |
Why?
|
| Locus Control Region | 1 | 2012 | 21 | 0.410 |
Why?
|
| Chromatin | 9 | 2023 | 2955 | 0.410 |
Why?
|
| Gastrula | 6 | 2016 | 82 | 0.400 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 3 | 2024 | 259 | 0.400 |
Why?
|
| Stromal Cells | 3 | 2015 | 1329 | 0.400 |
Why?
|
| Stem Cell Research | 1 | 2012 | 37 | 0.390 |
Why?
|
| Membrane Proteins | 12 | 2021 | 7847 | 0.390 |
Why?
|
| Cells, Cultured | 25 | 2024 | 18937 | 0.390 |
Why?
|
| Genomic Instability | 2 | 2007 | 709 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinases | 13 | 2018 | 1242 | 0.390 |
Why?
|
| RNA | 6 | 2024 | 2713 | 0.390 |
Why?
|
| Blood Physiological Phenomena | 2 | 2009 | 53 | 0.390 |
Why?
|
| Sequence Alignment | 19 | 2018 | 2178 | 0.380 |
Why?
|
| Nevus | 3 | 2012 | 205 | 0.380 |
Why?
|
| Homeostasis | 11 | 2021 | 3321 | 0.380 |
Why?
|
| Embryonic Induction | 4 | 2001 | 151 | 0.380 |
Why?
|
| Protein Methyltransferases | 1 | 2011 | 53 | 0.380 |
Why?
|
| Vertebrates | 5 | 2008 | 227 | 0.370 |
Why?
|
| Smad1 Protein | 3 | 2020 | 81 | 0.370 |
Why?
|
| Sexual Behavior, Animal | 2 | 2009 | 120 | 0.370 |
Why?
|
| Single-Cell Analysis | 5 | 2022 | 2447 | 0.370 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2023 | 634 | 0.370 |
Why?
|
| Nuclear Proteins | 10 | 2019 | 5789 | 0.370 |
Why?
|
| Forkhead Transcription Factors | 3 | 2015 | 1614 | 0.370 |
Why?
|
| Energy Metabolism | 2 | 2013 | 2878 | 0.360 |
Why?
|
| Cloning, Organism | 3 | 2011 | 50 | 0.360 |
Why?
|
| Metalloproteases | 1 | 2010 | 61 | 0.350 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2020 | 3634 | 0.350 |
Why?
|
| Methyltransferases | 1 | 2013 | 373 | 0.350 |
Why?
|
| Adenosine | 1 | 2015 | 805 | 0.350 |
Why?
|
| Body Patterning | 8 | 2019 | 632 | 0.350 |
Why?
|
| Autophagy | 4 | 2017 | 1326 | 0.340 |
Why?
|
| Injections, Intraocular | 1 | 2009 | 33 | 0.340 |
Why?
|
| DNA Topoisomerases, Type II | 2 | 2015 | 122 | 0.340 |
Why?
|
| Xenopus laevis | 11 | 2007 | 963 | 0.340 |
Why?
|
| Mutagenesis, Insertional | 2 | 2018 | 656 | 0.330 |
Why?
|
| Blood Circulation | 1 | 2010 | 248 | 0.330 |
Why?
|
| Heart Atria | 1 | 2015 | 1333 | 0.330 |
Why?
|
| Genome | 9 | 2016 | 1737 | 0.330 |
Why?
|
| Receptors, Growth Factor | 4 | 2002 | 326 | 0.320 |
Why?
|
| Models, Biological | 15 | 2021 | 9461 | 0.320 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2018 | 382 | 0.320 |
Why?
|
| Antimicrobial Cationic Peptides | 2 | 2008 | 352 | 0.320 |
Why?
|
| T-Lymphocytes | 10 | 2019 | 10175 | 0.320 |
Why?
|
| Muscular Dystrophies | 4 | 2013 | 390 | 0.320 |
Why?
|
| Clone Cells | 5 | 2024 | 1657 | 0.310 |
Why?
|
| Protein Binding | 13 | 2023 | 9345 | 0.310 |
Why?
|
| Cytokines | 6 | 2021 | 7373 | 0.310 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2023 | 790 | 0.310 |
Why?
|
| Genetic Linkage | 14 | 2012 | 2340 | 0.310 |
Why?
|
| Granulocytes | 4 | 2016 | 551 | 0.310 |
Why?
|
| Pyrimidines | 3 | 2021 | 3027 | 0.310 |
Why?
|
| Endopeptidases | 2 | 2007 | 774 | 0.310 |
Why?
|
| Genes, Duplicate | 2 | 2007 | 30 | 0.310 |
Why?
|
| Receptors, Cell Surface | 10 | 2002 | 2802 | 0.300 |
Why?
|
| Recombination, Genetic | 3 | 2011 | 1519 | 0.300 |
Why?
|
| Bone Morphogenetic Protein 4 | 8 | 2015 | 163 | 0.300 |
Why?
|
| RNA, Messenger | 30 | 2021 | 12758 | 0.300 |
Why?
|
| Adult Stem Cells | 2 | 2011 | 221 | 0.300 |
Why?
|
| Morphogenesis | 7 | 2021 | 741 | 0.300 |
Why?
|
| Organ Specificity | 11 | 2017 | 1964 | 0.300 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2024 | 502 | 0.300 |
Why?
|
| Skin Pigmentation | 3 | 2021 | 277 | 0.300 |
Why?
|
| Sequence Homology | 2 | 2007 | 196 | 0.300 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 2 | 2023 | 225 | 0.290 |
Why?
|
| Molecular Biology | 3 | 2016 | 575 | 0.290 |
Why?
|
| beta Catenin | 5 | 2012 | 1039 | 0.290 |
Why?
|
| Conserved Sequence | 11 | 2013 | 1162 | 0.290 |
Why?
|
| DNA Transposable Elements | 2 | 2011 | 754 | 0.290 |
Why?
|
| Transferrin | 1 | 2008 | 283 | 0.290 |
Why?
|
| Ubiquitin | 2 | 2021 | 839 | 0.290 |
Why?
|
| Receptors, Erythropoietin | 8 | 2007 | 144 | 0.290 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 13635 | 0.290 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2015 | 4570 | 0.290 |
Why?
|
| Anemia | 7 | 2019 | 1504 | 0.290 |
Why?
|
| Inflammation | 3 | 2022 | 10760 | 0.290 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2021 | 15908 | 0.290 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2008 | 180 | 0.290 |
Why?
|
| DNA | 18 | 2023 | 7196 | 0.290 |
Why?
|
| Gene Amplification | 2 | 2013 | 1087 | 0.290 |
Why?
|
| Microscopy, Acoustic | 1 | 2007 | 47 | 0.290 |
Why?
|
| Receptors, Transferrin | 2 | 2008 | 291 | 0.280 |
Why?
|
| Genes, APC | 1 | 2007 | 145 | 0.280 |
Why?
|
| Prostaglandins | 2 | 2021 | 398 | 0.280 |
Why?
|
| Neoplastic Stem Cells | 3 | 2010 | 1350 | 0.280 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2007 | 546 | 0.280 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2018 | 170 | 0.280 |
Why?
|
| Heat-Shock Response | 2 | 2007 | 179 | 0.270 |
Why?
|
| Anemia, Hypochromic | 4 | 2008 | 63 | 0.270 |
Why?
|
| Genomics | 9 | 2018 | 5822 | 0.270 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 1667 | 0.270 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 2137 | 0.270 |
Why?
|
| Collagen Type IV | 2 | 2023 | 126 | 0.270 |
Why?
|
| Synteny | 4 | 2011 | 77 | 0.270 |
Why?
|
| Zinc Fingers | 6 | 2000 | 578 | 0.270 |
Why?
|
| Orbit | 1 | 2009 | 457 | 0.270 |
Why?
|
| T-Box Domain Proteins | 4 | 2015 | 469 | 0.270 |
Why?
|
| DNA Copy Number Variations | 3 | 2013 | 2020 | 0.270 |
Why?
|
| Staining and Labeling | 2 | 2016 | 1081 | 0.270 |
Why?
|
| Hepatocytes | 6 | 2019 | 1231 | 0.270 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2007 | 189 | 0.270 |
Why?
|
| 16,16-Dimethylprostaglandin E2 | 3 | 2017 | 22 | 0.260 |
Why?
|
| Telomerase | 3 | 2021 | 744 | 0.260 |
Why?
|
| Oncogene Proteins | 5 | 2016 | 718 | 0.260 |
Why?
|
| Protein-Tyrosine Kinases | 9 | 2022 | 2425 | 0.260 |
Why?
|
| Myocardium | 4 | 2015 | 4724 | 0.260 |
Why?
|
| Polymerase Chain Reaction | 15 | 2003 | 6074 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2021 | 3599 | 0.260 |
Why?
|
| Aging | 6 | 2016 | 8699 | 0.260 |
Why?
|
| Bone Marrow Cells | 6 | 2018 | 2409 | 0.250 |
Why?
|
| Interleukin-8 | 3 | 2023 | 696 | 0.250 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2021 | 5672 | 0.250 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 5 | 1996 | 56 | 0.250 |
Why?
|
| Isoenzymes | 4 | 2014 | 1687 | 0.240 |
Why?
|
| S Phase | 2 | 2005 | 421 | 0.240 |
Why?
|
| Hemoglobins | 6 | 2020 | 1524 | 0.240 |
Why?
|
| Muscle, Skeletal | 8 | 2023 | 4947 | 0.240 |
Why?
|
| Lymphokines | 3 | 2002 | 925 | 0.240 |
Why?
|
| Spleen | 6 | 2020 | 2286 | 0.240 |
Why?
|
| Adamantane | 1 | 2005 | 148 | 0.240 |
Why?
|
| RNA Polymerase II | 3 | 2021 | 537 | 0.240 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2000 | 604 | 0.240 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2013 | 915 | 0.240 |
Why?
|
| Gene Regulatory Networks | 2 | 2013 | 1745 | 0.230 |
Why?
|
| History, 21st Century | 4 | 2018 | 1565 | 0.230 |
Why?
|
| Myosin Light Chains | 2 | 2015 | 121 | 0.230 |
Why?
|
| RNA Precursors | 2 | 2023 | 200 | 0.230 |
Why?
|
| Models, Genetic | 9 | 2012 | 3431 | 0.230 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2024 | 783 | 0.230 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2015 | 3492 | 0.230 |
Why?
|
| Leukocytes | 1 | 2012 | 2023 | 0.230 |
Why?
|
| Oligonucleotides, Antisense | 8 | 2008 | 458 | 0.230 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2008 | 549 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 8 | 2021 | 4408 | 0.220 |
Why?
|
| Hyperplasia | 1 | 2007 | 1150 | 0.220 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 661 | 0.220 |
Why?
|
| Multigene Family | 11 | 2020 | 1076 | 0.220 |
Why?
|
| Microscopy, Confocal | 7 | 2015 | 1970 | 0.220 |
Why?
|
| Chimera | 3 | 2018 | 453 | 0.220 |
Why?
|
| Nucleic Acid Amplification Techniques | 3 | 1999 | 330 | 0.220 |
Why?
|
| Neoplasm Proteins | 5 | 2020 | 3607 | 0.220 |
Why?
|
| Thrombopoietin | 2 | 2014 | 226 | 0.210 |
Why?
|
| Genome-Wide Association Study | 8 | 2021 | 12661 | 0.210 |
Why?
|
| Methylation | 3 | 2021 | 1077 | 0.210 |
Why?
|
| Heart Ventricles | 1 | 2015 | 3796 | 0.210 |
Why?
|
| Lampreys | 2 | 2020 | 32 | 0.210 |
Why?
|
| Bioethical Issues | 1 | 2004 | 120 | 0.210 |
Why?
|
| Antigens, Neoplasm | 2 | 2009 | 1985 | 0.210 |
Why?
|
| Transplantation, Heterologous | 3 | 2018 | 2382 | 0.210 |
Why?
|
| Cell Survival | 8 | 2021 | 5780 | 0.210 |
Why?
|
| Immunotherapy | 2 | 2021 | 4642 | 0.210 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 7995 | 0.210 |
Why?
|
| Blood Platelets | 5 | 2018 | 2478 | 0.210 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2003 | 150 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.210 |
Why?
|
| Induced Pluripotent Stem Cells | 6 | 2021 | 1850 | 0.210 |
Why?
|
| Intestinal Mucosa | 6 | 2008 | 3031 | 0.210 |
Why?
|
| Spectrin | 2 | 2000 | 170 | 0.210 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2013 | 3777 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.210 |
Why?
|
| History, 20th Century | 4 | 2018 | 2764 | 0.200 |
Why?
|
| Heart | 7 | 2015 | 4403 | 0.200 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2007 | 487 | 0.200 |
Why?
|
| Heme | 3 | 2018 | 313 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 16 | 2021 | 22115 | 0.200 |
Why?
|
| Transcriptional Activation | 6 | 2008 | 1755 | 0.200 |
Why?
|
| Frameshift Mutation | 2 | 2021 | 392 | 0.200 |
Why?
|
| Iron-Binding Proteins | 1 | 2002 | 79 | 0.200 |
Why?
|
| Proteins | 6 | 2010 | 6030 | 0.200 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 2001 | 96 | 0.200 |
Why?
|
| Mice, Knockout | 10 | 2018 | 14389 | 0.200 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2022 | 99 | 0.200 |
Why?
|
| Viral Envelope Proteins | 4 | 2017 | 640 | 0.190 |
Why?
|
| DNA Damage | 5 | 2024 | 2446 | 0.190 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2021 | 67 | 0.190 |
Why?
|
| Fish Proteins | 2 | 2020 | 47 | 0.190 |
Why?
|
| Kruppel-Like Transcription Factors | 4 | 2008 | 504 | 0.190 |
Why?
|
| Protein Biosynthesis | 5 | 2018 | 2100 | 0.190 |
Why?
|
| Cell Division | 6 | 2015 | 4457 | 0.190 |
Why?
|
| Fungal Proteins | 2 | 1995 | 907 | 0.190 |
Why?
|
| Cysteine Endopeptidases | 3 | 2002 | 552 | 0.190 |
Why?
|
| Infectious pancreatic necrosis virus | 1 | 2000 | 1 | 0.190 |
Why?
|
| Genetics, Medical | 2 | 2002 | 334 | 0.190 |
Why?
|
| Rhabdoviridae | 1 | 2000 | 5 | 0.190 |
Why?
|
| G-Quadruplexes | 1 | 2023 | 143 | 0.190 |
Why?
|
| Enzyme Activation | 16 | 2015 | 3591 | 0.180 |
Why?
|
| Culture Techniques | 3 | 2013 | 531 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 11 | 2016 | 4739 | 0.180 |
Why?
|
| RNA Virus Infections | 1 | 2000 | 19 | 0.180 |
Why?
|
| Dyskeratosis Congenita | 1 | 2021 | 73 | 0.180 |
Why?
|
| Species Specificity | 11 | 2011 | 2411 | 0.180 |
Why?
|
| Lymphopoiesis | 1 | 2021 | 133 | 0.180 |
Why?
|
| Gene Library | 5 | 2004 | 1055 | 0.180 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2000 | 83 | 0.180 |
Why?
|
| NF-E2 Transcription Factor | 3 | 2018 | 38 | 0.180 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2020 | 242 | 0.180 |
Why?
|
| Immunohistochemistry | 11 | 2015 | 11069 | 0.180 |
Why?
|
| Radiation Hybrid Mapping | 4 | 2006 | 18 | 0.180 |
Why?
|
| Electron Transport | 1 | 2021 | 210 | 0.180 |
Why?
|
| Neutrophils | 4 | 2023 | 3763 | 0.180 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2024 | 630 | 0.180 |
Why?
|
| Genomic Library | 2 | 2007 | 189 | 0.180 |
Why?
|
| Receptor, Notch1 | 2 | 2015 | 496 | 0.180 |
Why?
|
| Animal Use Alternatives | 1 | 2019 | 3 | 0.170 |
Why?
|
| Hematology | 1 | 2004 | 243 | 0.170 |
Why?
|
| K562 Cells | 3 | 2019 | 641 | 0.170 |
Why?
|
| Tendons | 1 | 2024 | 558 | 0.170 |
Why?
|
| Citric Acid Cycle | 1 | 2021 | 231 | 0.170 |
Why?
|
| Public Policy | 1 | 2004 | 557 | 0.170 |
Why?
|
| Autonomic Pathways | 1 | 2020 | 31 | 0.170 |
Why?
|
| Fishes | 2 | 2005 | 602 | 0.170 |
Why?
|
| Neurofibromin 1 | 1 | 2021 | 190 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 1788 | 0.170 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 4 | 2012 | 53 | 0.170 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2019 | 48 | 0.170 |
Why?
|
| Calmodulin | 1 | 2020 | 218 | 0.170 |
Why?
|
| 5-Aminolevulinate Synthetase | 2 | 2005 | 64 | 0.170 |
Why?
|
| Ubiquinone | 1 | 2021 | 183 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-jun | 3 | 2002 | 287 | 0.170 |
Why?
|
| Cord Blood Stem Cell Transplantation | 2 | 2013 | 305 | 0.170 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2024 | 937 | 0.170 |
Why?
|
| Drug Design | 1 | 2005 | 1045 | 0.170 |
Why?
|
| Response Elements | 3 | 2018 | 309 | 0.170 |
Why?
|
| Transcytosis | 1 | 2019 | 44 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 558 | 0.170 |
Why?
|
| Phosphoproteins | 5 | 2020 | 2446 | 0.170 |
Why?
|
| Neurons | 7 | 2016 | 9438 | 0.160 |
Why?
|
| Hair Color | 1 | 2020 | 131 | 0.160 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2006 | 1836 | 0.160 |
Why?
|
| Corneal Neovascularization | 1 | 2021 | 185 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 8 | 1988 | 2197 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 2812 | 0.160 |
Why?
|
| Cyclic AMP | 3 | 2024 | 1463 | 0.160 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1999 | 113 | 0.160 |
Why?
|
| Sulfonamides | 2 | 2021 | 1977 | 0.160 |
Why?
|
| Community Health Planning | 1 | 2000 | 164 | 0.160 |
Why?
|
| Fetal Blood | 3 | 2015 | 1347 | 0.160 |
Why?
|
| Antigens, Ly | 1 | 2020 | 294 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 495 | 0.160 |
Why?
|
| Semen Preservation | 1 | 1999 | 35 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 2 | 2021 | 2644 | 0.160 |
Why?
|
| Medical Oncology | 1 | 2011 | 2317 | 0.160 |
Why?
|
| Ferrochelatase | 1 | 2018 | 47 | 0.160 |
Why?
|
| Heat-Shock Proteins | 6 | 2006 | 795 | 0.160 |
Why?
|
| Histocompatibility Antigens | 1 | 2020 | 464 | 0.160 |
Why?
|
| Portraits as Topic | 1 | 2018 | 32 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2000 | 375 | 0.160 |
Why?
|
| Petromyzon | 1 | 2018 | 7 | 0.160 |
Why?
|
| Homozygote | 5 | 2013 | 1776 | 0.160 |
Why?
|
| Pyrimidine Dimers | 1 | 2018 | 18 | 0.160 |
Why?
|
| Tumor Microenvironment | 3 | 2021 | 3868 | 0.160 |
Why?
|
| Sequence Homology, Nucleic Acid | 6 | 2002 | 1058 | 0.160 |
Why?
|
| Genetic Markers | 5 | 2011 | 2601 | 0.160 |
Why?
|
| Genes, Switch | 2 | 2012 | 48 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 7 | 2015 | 3792 | 0.150 |
Why?
|
| Male | 40 | 2021 | 360358 | 0.150 |
Why?
|
| HEK293 Cells | 6 | 2020 | 4269 | 0.150 |
Why?
|
| U937 Cells | 1 | 2018 | 261 | 0.150 |
Why?
|
| Takifugu | 2 | 2011 | 7 | 0.150 |
Why?
|
| Pharmaceutical Preparations | 1 | 2006 | 1086 | 0.150 |
Why?
|
| Community-Institutional Relations | 1 | 2000 | 206 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2020 | 457 | 0.150 |
Why?
|
| DNA Primers | 12 | 2011 | 2817 | 0.150 |
Why?
|
| Inhibins | 1 | 1998 | 210 | 0.150 |
Why?
|
| Aquatic Organisms | 1 | 2018 | 42 | 0.150 |
Why?
|
| Yolk Sac | 4 | 2012 | 79 | 0.150 |
Why?
|
| Interferons | 1 | 2021 | 703 | 0.150 |
Why?
|
| Caffeic Acids | 1 | 2017 | 15 | 0.150 |
Why?
|
| Female | 38 | 2021 | 392148 | 0.150 |
Why?
|
| Mice, Nude | 3 | 2019 | 3605 | 0.150 |
Why?
|
| Computational Biology | 4 | 2020 | 3509 | 0.150 |
Why?
|
| Phenylethyl Alcohol | 1 | 2017 | 13 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-kit | 3 | 2018 | 727 | 0.150 |
Why?
|
| Fertility | 1 | 2022 | 769 | 0.150 |
Why?
|
| GTP Phosphohydrolases | 2 | 2018 | 517 | 0.150 |
Why?
|
| Anemia, Sideroblastic | 1 | 1998 | 109 | 0.150 |
Why?
|
| Cytoprotection | 1 | 2018 | 200 | 0.150 |
Why?
|
| Leukemia | 6 | 2016 | 1520 | 0.150 |
Why?
|
| Gene Flow | 1 | 2017 | 78 | 0.140 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2021 | 645 | 0.140 |
Why?
|
| Neuroepithelial Cells | 1 | 2017 | 23 | 0.140 |
Why?
|
| Journal Impact Factor | 1 | 2019 | 153 | 0.140 |
Why?
|
| Phospholipase C gamma | 2 | 2019 | 131 | 0.140 |
Why?
|
| Albinism | 2 | 2008 | 25 | 0.140 |
Why?
|
| Blotting, Western | 7 | 2017 | 5034 | 0.140 |
Why?
|
| Mesonephros | 4 | 2015 | 42 | 0.140 |
Why?
|
| Hospitals, Community | 1 | 2000 | 365 | 0.140 |
Why?
|
| Down-Regulation | 3 | 2021 | 2915 | 0.140 |
Why?
|
| RNA, Ribosomal | 1 | 2018 | 227 | 0.140 |
Why?
|
| Chemokines, CXC | 1 | 2018 | 416 | 0.140 |
Why?
|
| Selection, Genetic | 1 | 2021 | 868 | 0.140 |
Why?
|
| Thiophenes | 1 | 2021 | 569 | 0.140 |
Why?
|
| Pancreas | 3 | 2008 | 1690 | 0.140 |
Why?
|
| Sympathetic Nervous System | 1 | 2020 | 519 | 0.140 |
Why?
|
| Haploidy | 2 | 2011 | 126 | 0.140 |
Why?
|
| Recombinant Proteins | 12 | 2020 | 6520 | 0.140 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 370 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 8 | 2017 | 6126 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 789 | 0.140 |
Why?
|
| Transfection | 13 | 2015 | 5766 | 0.140 |
Why?
|
| Core Binding Factor alpha Subunits | 2 | 2015 | 25 | 0.140 |
Why?
|
| Hydrolases | 1 | 2017 | 147 | 0.140 |
Why?
|
| Bone Marrow Transplantation | 3 | 2018 | 2690 | 0.130 |
Why?
|
| Quantitative Trait Loci | 3 | 2020 | 2112 | 0.130 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 1739 | 0.130 |
Why?
|
| Neuroendocrine Cells | 1 | 2017 | 62 | 0.130 |
Why?
|
| Models, Organizational | 1 | 2000 | 544 | 0.130 |
Why?
|
| Immunophenotyping | 3 | 2019 | 1865 | 0.130 |
Why?
|
| Editorial Policies | 1 | 2021 | 458 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2016 | 2801 | 0.130 |
Why?
|
| Phosphorylation | 11 | 2019 | 8311 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3527 | 0.130 |
Why?
|
| Mediator Complex | 1 | 2016 | 106 | 0.130 |
Why?
|
| Bone Diseases, Developmental | 1 | 2017 | 131 | 0.130 |
Why?
|
| Cricetinae | 5 | 2007 | 2424 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 9 | 2011 | 3730 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2015 | 130 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 3 | 1998 | 1963 | 0.130 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2011 | 123 | 0.130 |
Why?
|
| SOXE Transcription Factors | 1 | 2016 | 73 | 0.130 |
Why?
|
| Fibroblasts | 4 | 2002 | 4137 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 2017 | 3688 | 0.130 |
Why?
|
| Granulocyte-Macrophage Progenitor Cells | 2 | 2012 | 21 | 0.130 |
Why?
|
| Protein Subunits | 2 | 2023 | 942 | 0.130 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2015 | 45 | 0.130 |
Why?
|
| Progesterone | 1 | 2020 | 742 | 0.130 |
Why?
|
| Cyclin B | 2 | 2005 | 104 | 0.130 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2017 | 166 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 17878 | 0.130 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 2533 | 0.130 |
Why?
|
| Mast Cells | 4 | 2001 | 1392 | 0.130 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2015 | 48 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2021 | 1113 | 0.130 |
Why?
|
| Melanins | 1 | 2017 | 289 | 0.130 |
Why?
|
| Hybrid Cells | 4 | 2000 | 422 | 0.130 |
Why?
|
| Epigenomics | 1 | 2021 | 942 | 0.120 |
Why?
|
| Structure-Activity Relationship | 2 | 2018 | 3074 | 0.120 |
Why?
|
| Islets of Langerhans | 1 | 2001 | 1340 | 0.120 |
Why?
|
| Dioxygenases | 2 | 2014 | 344 | 0.120 |
Why?
|
| Histone Demethylases | 1 | 2018 | 323 | 0.120 |
Why?
|
| Carrier Proteins | 3 | 2015 | 4935 | 0.120 |
Why?
|
| Motor Neurons | 1 | 2020 | 870 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2015 | 120 | 0.120 |
Why?
|
| GTPase-Activating Proteins | 3 | 2008 | 471 | 0.120 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 459 | 0.120 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2010 | 1608 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1996 | 418 | 0.120 |
Why?
|
| Molecular Probes | 1 | 2016 | 309 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 1932 | 0.120 |
Why?
|
| Transcription Factor AP-1 | 2 | 2015 | 319 | 0.120 |
Why?
|
| eIF-2 Kinase | 1 | 2015 | 145 | 0.120 |
Why?
|
| Myoblasts | 2 | 2018 | 231 | 0.120 |
Why?
|
| Societies, Scientific | 2 | 2007 | 222 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2021 | 1866 | 0.120 |
Why?
|
| Receptors, CXCR4 | 2 | 2017 | 727 | 0.120 |
Why?
|
| HeLa Cells | 4 | 2016 | 3087 | 0.120 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2014 | 62 | 0.120 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 656 | 0.120 |
Why?
|
| Genes, myc | 2 | 2008 | 390 | 0.120 |
Why?
|
| Mass Screening | 1 | 2010 | 5424 | 0.120 |
Why?
|
| Neural Stem Cells | 2 | 2019 | 887 | 0.120 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2015 | 183 | 0.120 |
Why?
|
| Uridine | 1 | 2014 | 140 | 0.110 |
Why?
|
| Mandibulofacial Dysostosis | 1 | 2014 | 36 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2019 | 526 | 0.110 |
Why?
|
| Mitochondrial Proteins | 2 | 2018 | 974 | 0.110 |
Why?
|
| Whole-Body Irradiation | 2 | 2005 | 432 | 0.110 |
Why?
|
| Ribosomes | 2 | 2015 | 500 | 0.110 |
Why?
|
| Time-Lapse Imaging | 1 | 2015 | 194 | 0.110 |
Why?
|
| Core Binding Factor beta Subunit | 2 | 2012 | 42 | 0.110 |
Why?
|
| Muscles | 4 | 2013 | 1573 | 0.110 |
Why?
|
| Circadian Clocks | 1 | 2016 | 164 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2014 | 0.110 |
Why?
|
| Chemokine CXCL12 | 2 | 2017 | 454 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2017 | 632 | 0.110 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 3705 | 0.110 |
Why?
|
| Pyridines | 1 | 2005 | 2874 | 0.110 |
Why?
|
| Genes, Lethal | 2 | 2011 | 223 | 0.110 |
Why?
|
| Tosylphenylalanyl Chloromethyl Ketone | 1 | 2013 | 8 | 0.110 |
Why?
|
| Spleen Focus-Forming Viruses | 2 | 1992 | 16 | 0.110 |
Why?
|
| Gamma Rays | 2 | 2005 | 318 | 0.110 |
Why?
|
| Protein Transport | 4 | 2019 | 1966 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2019 | 2546 | 0.110 |
Why?
|
| Polymorphism, Genetic | 4 | 2005 | 4242 | 0.110 |
Why?
|
| Hedgehog Proteins | 2 | 2012 | 768 | 0.110 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2014 | 88 | 0.110 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 3 | 2008 | 664 | 0.110 |
Why?
|
| Guided Tissue Regeneration | 1 | 2013 | 88 | 0.110 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2013 | 85 | 0.110 |
Why?
|
| Chemokines | 1 | 2017 | 954 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 1971 | 0.110 |
Why?
|
| Arteries | 1 | 2018 | 1122 | 0.110 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2017 | 547 | 0.110 |
Why?
|
| Binding Sites | 6 | 2023 | 6051 | 0.110 |
Why?
|
| Cell Nucleus Structures | 2 | 2002 | 15 | 0.110 |
Why?
|
| Graft Survival | 3 | 2013 | 3820 | 0.110 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1745 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 1027 | 0.100 |
Why?
|
| Microcephaly | 2 | 2014 | 425 | 0.100 |
Why?
|
| Cardiac Myosins | 1 | 2013 | 128 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2013 | 203 | 0.100 |
Why?
|
| Nitric Oxide | 2 | 2014 | 2135 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 1998 | 865 | 0.100 |
Why?
|
| Leukemia, Experimental | 2 | 1992 | 225 | 0.100 |
Why?
|
| Genetic Complementation Test | 3 | 2017 | 555 | 0.100 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2015 | 485 | 0.100 |
Why?
|
| DNA Mutational Analysis | 4 | 2014 | 4110 | 0.100 |
Why?
|
| Iodide Peroxidase | 1 | 2014 | 294 | 0.100 |
Why?
|
| Immunity, Innate | 2 | 2004 | 3045 | 0.100 |
Why?
|
| Codon, Nonsense | 4 | 2015 | 284 | 0.100 |
Why?
|
| Cell Count | 1 | 2016 | 1835 | 0.100 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 10 | 2001 | 438 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2012 | 66 | 0.100 |
Why?
|
| Research | 1 | 2021 | 1977 | 0.100 |
Why?
|
| Point Mutation | 2 | 2015 | 1595 | 0.100 |
Why?
|
| Lasers | 1 | 2016 | 952 | 0.100 |
Why?
|
| Time Factors | 9 | 2018 | 39913 | 0.100 |
Why?
|
| Mutation, Missense | 3 | 2011 | 2570 | 0.100 |
Why?
|
| Cell Transplantation | 2 | 2004 | 472 | 0.100 |
Why?
|
| Angiopoietin-1 | 1 | 2012 | 122 | 0.100 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 340 | 0.100 |
Why?
|
| Radiation, Ionizing | 2 | 2012 | 251 | 0.100 |
Why?
|
| Estrogens | 1 | 2019 | 1521 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2002 | 748 | 0.100 |
Why?
|
| Hypercholesterolemia | 1 | 2019 | 1141 | 0.100 |
Why?
|
| Lipids | 1 | 2023 | 3332 | 0.100 |
Why?
|
| Cerebellar Cortex | 1 | 2012 | 107 | 0.100 |
Why?
|
| Alleles | 7 | 2016 | 6861 | 0.100 |
Why?
|
| Genes, Recessive | 2 | 2012 | 623 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2000 | 940 | 0.100 |
Why?
|
| Carboxypeptidases | 1 | 1991 | 155 | 0.100 |
Why?
|
| TCF Transcription Factors | 1 | 2012 | 138 | 0.100 |
Why?
|
| Codon, Terminator | 2 | 2018 | 124 | 0.100 |
Why?
|
| Estradiol | 1 | 2019 | 1937 | 0.100 |
Why?
|
| Leukopoiesis | 2 | 2001 | 54 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2016 | 3612 | 0.090 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 332 | 0.090 |
Why?
|
| Body Size | 1 | 2014 | 463 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2011 | 473 | 0.090 |
Why?
|
| RNA Splice Sites | 1 | 2012 | 210 | 0.090 |
Why?
|
| Cytosine | 1 | 2012 | 211 | 0.090 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2012 | 150 | 0.090 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2011 | 15 | 0.090 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2011 | 152 | 0.090 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2013 | 266 | 0.090 |
Why?
|
| Survival Rate | 2 | 2020 | 12719 | 0.090 |
Why?
|
| Ethylnitrosourea | 1 | 2011 | 51 | 0.090 |
Why?
|
| Dystroglycans | 1 | 2011 | 62 | 0.090 |
Why?
|
| COS Cells | 3 | 2012 | 1130 | 0.090 |
Why?
|
| Branchial Region | 2 | 2008 | 37 | 0.090 |
Why?
|
| Blotting, Northern | 5 | 2005 | 1545 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 699 | 0.090 |
Why?
|
| Transplantation Conditioning | 2 | 2011 | 1590 | 0.090 |
Why?
|
| Coculture Techniques | 3 | 2018 | 1336 | 0.090 |
Why?
|
| Indoles | 2 | 2016 | 1830 | 0.090 |
Why?
|
| Cardiovascular Abnormalities | 2 | 2003 | 143 | 0.090 |
Why?
|
| Laminin | 1 | 2012 | 408 | 0.090 |
Why?
|
| Basophils | 1 | 1993 | 407 | 0.090 |
Why?
|
| Mice, Inbred Strains | 3 | 2017 | 1759 | 0.090 |
Why?
|
| Thrombopoiesis | 2 | 2018 | 164 | 0.090 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2003 | 271 | 0.090 |
Why?
|
| Animal Husbandry | 1 | 2011 | 64 | 0.090 |
Why?
|
| Stress, Mechanical | 1 | 1996 | 1674 | 0.090 |
Why?
|
| Antiporters | 2 | 2017 | 276 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2208 | 0.090 |
Why?
|
| Bone Morphogenetic Protein Receptors | 3 | 2006 | 46 | 0.090 |
Why?
|
| Rhodamines | 1 | 2011 | 178 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2864 | 0.090 |
Why?
|
| Sonication | 1 | 2011 | 79 | 0.090 |
Why?
|
| Automation, Laboratory | 1 | 2011 | 102 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2009 | 2509 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 2001 | 286 | 0.090 |
Why?
|
| Nervous System | 2 | 2011 | 545 | 0.090 |
Why?
|
| Radiation Tolerance | 1 | 2012 | 478 | 0.090 |
Why?
|
| Mutagens | 1 | 2011 | 179 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2021 | 1404 | 0.090 |
Why?
|
| Chimerism | 1 | 2011 | 155 | 0.090 |
Why?
|
| Optics and Photonics | 1 | 2011 | 306 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 1454 | 0.090 |
Why?
|
| Flavonoids | 1 | 2013 | 445 | 0.090 |
Why?
|
| Pancytopenia | 1 | 2010 | 102 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2011 | 4117 | 0.080 |
Why?
|
| Multiprotein Complexes | 2 | 2019 | 1118 | 0.080 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2010 | 122 | 0.080 |
Why?
|
| Drug Administration Routes | 1 | 2009 | 150 | 0.080 |
Why?
|
| Bromodeoxyuridine | 2 | 2007 | 310 | 0.080 |
Why?
|
| Cholesterol | 1 | 2019 | 2903 | 0.080 |
Why?
|
| Tissue Fixation | 1 | 2011 | 241 | 0.080 |
Why?
|
| Intestines | 3 | 2008 | 1909 | 0.080 |
Why?
|
| Antigens, CD | 3 | 2018 | 3998 | 0.080 |
Why?
|
| NIH 3T3 Cells | 2 | 2012 | 669 | 0.080 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2012 | 265 | 0.080 |
Why?
|
| Receptors, Immunologic | 2 | 2015 | 1409 | 0.080 |
Why?
|
| Isoxazoles | 1 | 2011 | 232 | 0.080 |
Why?
|
| Lymphocyte Activation | 2 | 2019 | 5463 | 0.080 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2009 | 100 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 697 | 0.080 |
Why?
|
| Formaldehyde | 1 | 2011 | 357 | 0.080 |
Why?
|
| Acetylcysteine | 1 | 2010 | 260 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2013 | 733 | 0.080 |
Why?
|
| Phenylhydrazines | 1 | 2008 | 28 | 0.080 |
Why?
|
| Polyploidy | 2 | 2007 | 119 | 0.080 |
Why?
|
| Gene Duplication | 2 | 2007 | 314 | 0.080 |
Why?
|
| Myeloproliferative Disorders | 1 | 2015 | 611 | 0.080 |
Why?
|
| Myeloid Progenitor Cells | 2 | 2018 | 112 | 0.080 |
Why?
|
| Hyperglycemia | 1 | 2017 | 1375 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 1492 | 0.080 |
Why?
|
| Cell Biology | 1 | 2009 | 90 | 0.080 |
Why?
|
| Protoporphyrinogen Oxidase | 1 | 2008 | 3 | 0.080 |
Why?
|
| Porphyria, Variegate | 1 | 2008 | 3 | 0.080 |
Why?
|
| 3T3 Cells | 6 | 1997 | 1085 | 0.080 |
Why?
|
| Liver Failure, Acute | 1 | 2010 | 181 | 0.080 |
Why?
|
| STAT5 Transcription Factor | 2 | 2007 | 265 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2006 | 2674 | 0.080 |
Why?
|
| Iron-Sulfur Proteins | 2 | 2006 | 83 | 0.080 |
Why?
|
| Histone Deacetylase 1 | 1 | 2009 | 133 | 0.080 |
Why?
|
| Nuclear Pore | 1 | 2008 | 62 | 0.080 |
Why?
|
| Cell Nucleus | 3 | 2004 | 2894 | 0.080 |
Why?
|
| Eosinophils | 1 | 1993 | 953 | 0.080 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2008 | 23 | 0.080 |
Why?
|
| Fluorescence | 1 | 2011 | 756 | 0.080 |
Why?
|
| Gonads | 2 | 2005 | 109 | 0.080 |
Why?
|
| Cleavage Stage, Ovum | 1 | 2008 | 44 | 0.080 |
Why?
|
| RNA Interference | 2 | 2015 | 2830 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2017 | 2624 | 0.080 |
Why?
|
| Major Histocompatibility Complex | 1 | 2011 | 870 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2016 | 4010 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 1509 | 0.070 |
Why?
|
| Expressed Sequence Tags | 6 | 2007 | 250 | 0.070 |
Why?
|
| Monocytes | 1 | 2017 | 2565 | 0.070 |
Why?
|
| Genes, bcl-2 | 1 | 2008 | 119 | 0.070 |
Why?
|
| Central Nervous System Diseases | 1 | 2012 | 521 | 0.070 |
Why?
|
| Age of Onset | 2 | 2014 | 3302 | 0.070 |
Why?
|
| United States | 5 | 2020 | 72272 | 0.070 |
Why?
|
| Saliva | 3 | 1986 | 828 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2012 | 1202 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2008 | 613 | 0.070 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2012 | 612 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2011 | 685 | 0.070 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2007 | 26 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 2 | 2018 | 1066 | 0.070 |
Why?
|
| Antigens, CD34 | 3 | 2017 | 658 | 0.070 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2008 | 163 | 0.070 |
Why?
|
| Swimming | 1 | 2008 | 208 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6474 | 0.070 |
Why?
|
| Anniversaries and Special Events | 1 | 2008 | 95 | 0.070 |
Why?
|
| GATA3 Transcription Factor | 3 | 1993 | 154 | 0.070 |
Why?
|
| Allelic Imbalance | 1 | 2007 | 77 | 0.070 |
Why?
|
| Mosaicism | 1 | 2011 | 474 | 0.070 |
Why?
|
| Cell Death | 3 | 2005 | 1677 | 0.070 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2010 | 597 | 0.070 |
Why?
|
| Aphidicolin | 1 | 2006 | 37 | 0.070 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2007 | 89 | 0.070 |
Why?
|
| Dysgammaglobulinemia | 1 | 1986 | 19 | 0.070 |
Why?
|
| Enterocytes | 3 | 2008 | 220 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 1551 | 0.070 |
Why?
|
| Drug Tolerance | 1 | 2008 | 367 | 0.070 |
Why?
|
| Ikaros Transcription Factor | 1 | 2008 | 232 | 0.070 |
Why?
|
| Growth Substances | 3 | 2004 | 768 | 0.070 |
Why?
|
| IgA Deficiency | 1 | 1986 | 39 | 0.070 |
Why?
|
| Neuropilin-1 | 2 | 2004 | 90 | 0.070 |
Why?
|
| Cytogenetics | 1 | 2007 | 198 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2021 | 4391 | 0.070 |
Why?
|
| Nocodazole | 1 | 2006 | 95 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 2057 | 0.070 |
Why?
|
| Forecasting | 3 | 2004 | 2924 | 0.070 |
Why?
|
| alpha-Crystallins | 1 | 2006 | 4 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 1128 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2000 | 767 | 0.070 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2008 | 150 | 0.070 |
Why?
|
| gamma-Crystallins | 1 | 2006 | 9 | 0.070 |
Why?
|
| Eye Diseases | 1 | 2012 | 653 | 0.070 |
Why?
|
| Spliceosomes | 1 | 2007 | 119 | 0.070 |
Why?
|
| Stem Cell Factor | 1 | 2007 | 195 | 0.070 |
Why?
|
| Physical Chromosome Mapping | 3 | 2007 | 183 | 0.070 |
Why?
|
| Spermatozoa | 2 | 2002 | 629 | 0.070 |
Why?
|
| Substrate Specificity | 3 | 2002 | 1790 | 0.070 |
Why?
|
| Ploidies | 1 | 2007 | 285 | 0.070 |
Why?
|
| Acetaminophen | 1 | 2010 | 555 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2291 | 0.070 |
Why?
|
| X Chromosome | 1 | 1990 | 816 | 0.070 |
Why?
|
| Tamoxifen | 1 | 2011 | 965 | 0.070 |
Why?
|
| Exons | 8 | 2005 | 2381 | 0.070 |
Why?
|
| GATA Transcription Factors | 1 | 2006 | 29 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 489 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2009 | 705 | 0.070 |
Why?
|
| DNA Repair | 1 | 2015 | 2043 | 0.060 |
Why?
|
| Glutaredoxins | 1 | 2005 | 32 | 0.060 |
Why?
|
| Cyclin B1 | 1 | 2005 | 58 | 0.060 |
Why?
|
| Somites | 1 | 2006 | 60 | 0.060 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2008 | 477 | 0.060 |
Why?
|
| Eye Proteins | 3 | 2008 | 632 | 0.060 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2005 | 41 | 0.060 |
Why?
|
| Erythroblasts | 1 | 2006 | 142 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 3 | 2005 | 254 | 0.060 |
Why?
|
| Heart Diseases | 2 | 2012 | 2778 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2006 | 251 | 0.060 |
Why?
|
| Cricetulus | 1 | 2007 | 814 | 0.060 |
Why?
|
| Immune System | 2 | 2008 | 791 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2008 | 2561 | 0.060 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1661 | 0.060 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2005 | 37 | 0.060 |
Why?
|
| Dissection | 1 | 2007 | 297 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2005 | 63 | 0.060 |
Why?
|
| Megakaryocytes | 3 | 2012 | 566 | 0.060 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1989 | 592 | 0.060 |
Why?
|
| Muscle Proteins | 2 | 2007 | 1152 | 0.060 |
Why?
|
| Adenosine Deaminase | 1 | 2007 | 251 | 0.060 |
Why?
|
| Genome, Human | 4 | 2017 | 4421 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2014 | 1545 | 0.060 |
Why?
|
| Lymphocytes | 3 | 2017 | 2604 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2014 | 1169 | 0.060 |
Why?
|
| Hepatectomy | 1 | 2008 | 557 | 0.060 |
Why?
|
| CHO Cells | 1 | 2007 | 1387 | 0.060 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2014 | 1394 | 0.060 |
Why?
|
| Radiation Chimera | 1 | 2004 | 215 | 0.060 |
Why?
|
| HIV | 3 | 1988 | 1579 | 0.060 |
Why?
|
| Anion Transport Proteins | 1 | 2005 | 141 | 0.060 |
Why?
|
| Rats | 9 | 2011 | 23717 | 0.060 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 719 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 2569 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 1056 | 0.060 |
Why?
|
| Neuropilin-2 | 1 | 2004 | 55 | 0.060 |
Why?
|
| Ear, Inner | 1 | 2008 | 425 | 0.060 |
Why?
|
| Teratoma | 1 | 2007 | 404 | 0.060 |
Why?
|
| Mice, Mutant Strains | 3 | 2015 | 1748 | 0.060 |
Why?
|
| AIDS-Related Complex | 4 | 1987 | 107 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2020 | 4488 | 0.060 |
Why?
|
| Intestinal Neoplasms | 1 | 2007 | 314 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2006 | 397 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2011 | 1799 | 0.060 |
Why?
|
| Consensus Sequence | 2 | 1995 | 364 | 0.060 |
Why?
|
| Leukemia, T-Cell | 1 | 2004 | 101 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2004 | 1646 | 0.060 |
Why?
|
| Ion Transport | 1 | 2005 | 320 | 0.060 |
Why?
|
| Genetic Variation | 3 | 2017 | 6561 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 2238 | 0.060 |
Why?
|
| Lens, Crystalline | 1 | 2006 | 387 | 0.060 |
Why?
|
| Embryoid Bodies | 1 | 2024 | 65 | 0.060 |
Why?
|
| Bacteria | 2 | 1999 | 2192 | 0.060 |
Why?
|
| GTP-Binding Proteins | 2 | 1999 | 949 | 0.060 |
Why?
|
| Injections | 1 | 2007 | 832 | 0.060 |
Why?
|
| Molecular Imaging | 1 | 2011 | 814 | 0.060 |
Why?
|
| Neuropeptides | 2 | 2002 | 944 | 0.060 |
Why?
|
| Hemochromatosis | 1 | 2005 | 174 | 0.060 |
Why?
|
| Gene Order | 1 | 2004 | 169 | 0.060 |
Why?
|
| Protein Multimerization | 2 | 2023 | 982 | 0.060 |
Why?
|
| Anemia, Dyserythropoietic, Congenital | 1 | 2003 | 15 | 0.050 |
Why?
|
| Tissue Distribution | 4 | 2001 | 2261 | 0.050 |
Why?
|
| Genotype | 3 | 2014 | 12978 | 0.050 |
Why?
|
| Endocardium | 2 | 1995 | 246 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3088 | 0.050 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2005 | 170 | 0.050 |
Why?
|
| Crosses, Genetic | 3 | 2005 | 750 | 0.050 |
Why?
|
| Lysine | 2 | 2018 | 993 | 0.050 |
Why?
|
| PAX2 Transcription Factor | 2 | 2018 | 86 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2005 | 412 | 0.050 |
Why?
|
| Carbon Tetrachloride | 1 | 2003 | 72 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4308 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 3415 | 0.050 |
Why?
|
| Protein Kinase C-delta | 1 | 2023 | 114 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 29600 | 0.050 |
Why?
|
| Tubulin | 1 | 2006 | 692 | 0.050 |
Why?
|
| Microfilament Proteins | 2 | 2005 | 1130 | 0.050 |
Why?
|
| SUMO-1 Protein | 1 | 2002 | 35 | 0.050 |
Why?
|
| Environment | 1 | 2008 | 1123 | 0.050 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2002 | 61 | 0.050 |
Why?
|
| Databases, Genetic | 2 | 2007 | 1742 | 0.050 |
Why?
|
| Isotope Labeling | 1 | 2004 | 392 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2002 | 228 | 0.050 |
Why?
|
| Axons | 1 | 2010 | 1671 | 0.050 |
Why?
|
| Birds | 1 | 2003 | 168 | 0.050 |
Why?
|
| Equipment Design | 1 | 2010 | 3501 | 0.050 |
Why?
|
| Interneurons | 1 | 2007 | 582 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2023 | 349 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor, Endocrine-Gland-Derived | 1 | 2001 | 3 | 0.050 |
Why?
|
| Protein Conformation | 3 | 2023 | 3965 | 0.050 |
Why?
|
| Antigens, Differentiation | 2 | 2002 | 908 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 1074 | 0.050 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2003 | 164 | 0.050 |
Why?
|
| Drug Evaluation | 1 | 2003 | 641 | 0.050 |
Why?
|
| Heterochromatin | 1 | 2004 | 291 | 0.050 |
Why?
|
| DiGeorge Syndrome | 1 | 2003 | 185 | 0.050 |
Why?
|
| Light | 1 | 2008 | 1352 | 0.050 |
Why?
|
| Dystrophin | 1 | 2003 | 281 | 0.050 |
Why?
|
| Colony-Forming Units Assay | 2 | 2012 | 351 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2008 | 1386 | 0.050 |
Why?
|
| Molecular Weight | 2 | 2003 | 2185 | 0.050 |
Why?
|
| Melanosomes | 1 | 2021 | 33 | 0.050 |
Why?
|
| Ovum | 1 | 2002 | 187 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2017 | 9172 | 0.050 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 1896 | 0.050 |
Why?
|
| Fibrinogen | 2 | 2018 | 887 | 0.050 |
Why?
|
| Monophenol Monooxygenase | 1 | 2021 | 72 | 0.050 |
Why?
|
| Anemia, Hemolytic | 1 | 2002 | 162 | 0.050 |
Why?
|
| Denmark | 1 | 2004 | 770 | 0.050 |
Why?
|
| Mitogens | 1 | 2001 | 229 | 0.050 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2018 | 651 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2012 | 2090 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2734 | 0.050 |
Why?
|
| Autoantigens | 1 | 2005 | 888 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2018 | 988 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 3419 | 0.050 |
Why?
|
| Cryopreservation | 2 | 2013 | 728 | 0.050 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 1768 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2011 | 2565 | 0.050 |
Why?
|
| Seizures | 1 | 2014 | 2954 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2008 | 2202 | 0.050 |
Why?
|
| Paired Box Transcription Factors | 1 | 2001 | 206 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2008 | 1528 | 0.050 |
Why?
|
| Electroporation | 2 | 2015 | 233 | 0.050 |
Why?
|
| Open Reading Frames | 2 | 2004 | 813 | 0.050 |
Why?
|
| Smad Proteins | 1 | 2001 | 156 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2004 | 566 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2002 | 386 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 980 | 0.050 |
Why?
|
| Sequence Deletion | 4 | 2013 | 1490 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 1738 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 4745 | 0.040 |
Why?
|
| Chromosome Walking | 1 | 2000 | 25 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8645 | 0.040 |
Why?
|
| Mammals | 4 | 2003 | 1131 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2015 | 411 | 0.040 |
Why?
|
| Holoprosencephaly | 1 | 2000 | 22 | 0.040 |
Why?
|
| Health Planning Councils | 1 | 2000 | 11 | 0.040 |
Why?
|
| Chromosome Inversion | 1 | 2000 | 120 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2006 | 1034 | 0.040 |
Why?
|
| Milk Proteins | 1 | 2001 | 162 | 0.040 |
Why?
|
| Meningioma | 1 | 1989 | 1215 | 0.040 |
Why?
|
| Cilia | 1 | 2024 | 492 | 0.040 |
Why?
|
| Prothrombin | 1 | 2000 | 190 | 0.040 |
Why?
|
| Cataract | 1 | 2006 | 831 | 0.040 |
Why?
|
| Chromosome Banding | 1 | 2000 | 260 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2004 | 787 | 0.040 |
Why?
|
| Heterozygote | 1 | 2007 | 2780 | 0.040 |
Why?
|
| Ligands | 2 | 2019 | 3268 | 0.040 |
Why?
|
| Meningeal Neoplasms | 1 | 1989 | 1245 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2019 | 67 | 0.040 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2019 | 69 | 0.040 |
Why?
|
| Extracellular Matrix | 3 | 2017 | 1718 | 0.040 |
Why?
|
| Horses | 1 | 2020 | 300 | 0.040 |
Why?
|
| SNARE Proteins | 1 | 2019 | 80 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2023 | 650 | 0.040 |
Why?
|
| Microscopy, Atomic Force | 1 | 2020 | 253 | 0.040 |
Why?
|
| Caveolins | 1 | 2019 | 102 | 0.040 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2019 | 58 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2020 | 211 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2000 | 343 | 0.040 |
Why?
|
| Genetic Techniques | 2 | 2015 | 428 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 1998 | 343 | 0.040 |
Why?
|
| Epitopes | 1 | 2005 | 2501 | 0.040 |
Why?
|
| Hematocrit | 1 | 2000 | 623 | 0.040 |
Why?
|
| Erythrocyte Membrane | 2 | 2002 | 439 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39063 | 0.040 |
Why?
|
| Organizational Case Studies | 1 | 2000 | 301 | 0.040 |
Why?
|
| Autoimmunity | 2 | 2017 | 1350 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1999 | 206 | 0.040 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2005 | 829 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 56 | 0.040 |
Why?
|
| Ontario | 1 | 2000 | 397 | 0.040 |
Why?
|
| Denervation | 1 | 2020 | 265 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2000 | 619 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2007 | 1807 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2020 | 217 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2023 | 1989 | 0.040 |
Why?
|
| Cell Separation | 2 | 2017 | 1718 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2005 | 781 | 0.040 |
Why?
|
| Hemolysis | 1 | 2000 | 415 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2003 | 3206 | 0.040 |
Why?
|
| Necrosis | 1 | 2003 | 1610 | 0.040 |
Why?
|
| Receptors, Parathyroid Hormone | 1 | 1999 | 332 | 0.040 |
Why?
|
| Acrylic Resins | 1 | 1999 | 135 | 0.040 |
Why?
|
| Genes, RAG-1 | 1 | 1998 | 67 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2019 | 226 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2014 | 3805 | 0.040 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2018 | 20 | 0.040 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1998 | 329 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 2467 | 0.040 |
Why?
|
| Racemases and Epimerases | 1 | 2019 | 114 | 0.040 |
Why?
|
| Cell Fusion | 1 | 2018 | 294 | 0.040 |
Why?
|
| Peroxidase | 1 | 2001 | 610 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2019 | 126 | 0.040 |
Why?
|
| Elasticity | 1 | 2020 | 655 | 0.040 |
Why?
|
| Community Networks | 1 | 2000 | 201 | 0.040 |
Why?
|
| Centromere | 1 | 1999 | 212 | 0.040 |
Why?
|
| Africa, Eastern | 1 | 2017 | 76 | 0.040 |
Why?
|
| Adrenalectomy | 1 | 2020 | 346 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 15498 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 20988 | 0.040 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2019 | 250 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1998 | 191 | 0.040 |
Why?
|
| Cell Nucleolus | 1 | 2018 | 156 | 0.040 |
Why?
|
| Carcinoma | 1 | 1989 | 2327 | 0.040 |
Why?
|
| Allyl Compounds | 1 | 2017 | 22 | 0.040 |
Why?
|
| Cell Compartmentation | 1 | 1998 | 384 | 0.040 |
Why?
|
| Suppression, Genetic | 1 | 2017 | 190 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2002 | 1626 | 0.040 |
Why?
|
| Anura | 1 | 2017 | 80 | 0.040 |
Why?
|
| Mitochondrial Membranes | 1 | 2018 | 176 | 0.040 |
Why?
|
| Hospital Information Systems | 1 | 2000 | 394 | 0.040 |
Why?
|
| Risk Factors | 2 | 2022 | 74115 | 0.040 |
Why?
|
| Blotting, Southern | 3 | 2007 | 777 | 0.040 |
Why?
|
| Linkage Disequilibrium | 2 | 2016 | 1994 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2020 | 552 | 0.040 |
Why?
|
| Activins | 1 | 1998 | 210 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2021 | 1755 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2020 | 898 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 1998 | 257 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 2002 | 913 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2017 | 186 | 0.030 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 1996 | 28 | 0.030 |
Why?
|
| Leukemia, Erythroblastic, Acute | 3 | 1991 | 176 | 0.030 |
Why?
|
| Dimerization | 1 | 1998 | 890 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2005 | 2115 | 0.030 |
Why?
|
| Porphobilinogen Synthase | 1 | 1996 | 27 | 0.030 |
Why?
|
| Muridae | 1 | 1996 | 56 | 0.030 |
Why?
|
| Introns | 3 | 2005 | 968 | 0.030 |
Why?
|
| Endosomes | 1 | 2019 | 522 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 2000 | 537 | 0.030 |
Why?
|
| Carps | 1 | 2016 | 51 | 0.030 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 1996 | 82 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 1999 | 783 | 0.030 |
Why?
|
| Ectoderm | 1 | 1996 | 137 | 0.030 |
Why?
|
| Parabiosis | 1 | 2016 | 64 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1996 | 153 | 0.030 |
Why?
|
| Catalytic Domain | 2 | 2014 | 704 | 0.030 |
Why?
|
| Pedigree | 2 | 2014 | 4539 | 0.030 |
Why?
|
| Simian virus 40 | 1 | 1996 | 291 | 0.030 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1996 | 158 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2018 | 562 | 0.030 |
Why?
|
| Mast-Cell Sarcoma | 1 | 1995 | 46 | 0.030 |
Why?
|
| Alternative Splicing | 2 | 2004 | 1088 | 0.030 |
Why?
|
| Plasmids | 2 | 2012 | 2265 | 0.030 |
Why?
|
| Meiosis | 2 | 2013 | 327 | 0.030 |
Why?
|
| Heparitin Sulfate | 1 | 2017 | 223 | 0.030 |
Why?
|
| Luciferases | 2 | 2013 | 712 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2016 | 189 | 0.030 |
Why?
|
| Thrombosis | 1 | 2009 | 2943 | 0.030 |
Why?
|
| Genes, Immunoglobulin | 1 | 1996 | 285 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2016 | 150 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2007 | 1727 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2019 | 548 | 0.030 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 1995 | 83 | 0.030 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1996 | 285 | 0.030 |
Why?
|
| Dogs | 1 | 2020 | 3838 | 0.030 |
Why?
|
| Dexamethasone | 2 | 2018 | 1947 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1996 | 419 | 0.030 |
Why?
|
| Software | 2 | 2007 | 4431 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2011 | 7960 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2018 | 659 | 0.030 |
Why?
|
| Cell Transformation, Viral | 1 | 1996 | 526 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2003 | 1160 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 1995 | 140 | 0.030 |
Why?
|
| Tyrosine | 1 | 2019 | 1440 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2231 | 0.030 |
Why?
|
| Protein Isoforms | 3 | 2007 | 1697 | 0.030 |
Why?
|
| Quinazolines | 2 | 2017 | 1371 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2017 | 592 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 704 | 0.030 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2015 | 90 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 602 | 0.030 |
Why?
|
| Fertilization in Vitro | 2 | 2003 | 1292 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 10754 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 2 | 2002 | 1336 | 0.030 |
Why?
|
| Thrombocytopenia | 2 | 2016 | 1182 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 1320 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 994 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1995 | 420 | 0.030 |
Why?
|
| DNA, Neoplasm | 3 | 2006 | 1743 | 0.030 |
Why?
|
| Research Design | 1 | 2011 | 6174 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1996 | 659 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1998 | 817 | 0.030 |
Why?
|
| Yeasts | 1 | 1996 | 278 | 0.030 |
Why?
|
| Ceramides | 1 | 1996 | 200 | 0.030 |
Why?
|
| Aminoacylation | 1 | 2014 | 9 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 710 | 0.030 |
Why?
|
| Cyclins | 1 | 1996 | 594 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2015 | 255 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2003 | 1297 | 0.030 |
Why?
|
| Sirolimus | 1 | 2021 | 1533 | 0.030 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2013 | 21 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1991 | 851 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 1995 | 439 | 0.030 |
Why?
|
| Hydroxyurea | 1 | 2015 | 282 | 0.030 |
Why?
|
| Genetics, Population | 2 | 2011 | 935 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2001 | 4341 | 0.030 |
Why?
|
| Culture Media | 1 | 2016 | 895 | 0.030 |
Why?
|
| Cytarabine | 1 | 1995 | 697 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 2252 | 0.030 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 9026 | 0.030 |
Why?
|
| Butyric Acid | 1 | 1993 | 51 | 0.030 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 1993 | 92 | 0.030 |
Why?
|
| Fibronectins | 1 | 2017 | 723 | 0.030 |
Why?
|
| Drosophila melanogaster | 2 | 2019 | 1712 | 0.030 |
Why?
|
| Pseudogenes | 1 | 2013 | 104 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1996 | 655 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2018 | 42188 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2003 | 1503 | 0.030 |
Why?
|
| Sex Determination Processes | 1 | 2013 | 60 | 0.030 |
Why?
|
| Organoids | 1 | 2019 | 744 | 0.030 |
Why?
|
| Receptors, Interleukin-3 | 1 | 1992 | 29 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1892 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 1999 | 1803 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2004 | 3672 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 1993 | 269 | 0.030 |
Why?
|
| Butyrates | 1 | 1993 | 169 | 0.030 |
Why?
|
| Chondrogenesis | 1 | 2014 | 238 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 1995 | 455 | 0.030 |
Why?
|
| Carboxypeptidases A | 1 | 1991 | 37 | 0.030 |
Why?
|
| Adherens Junctions | 1 | 2012 | 89 | 0.020 |
Why?
|
| Antibodies, Viral | 4 | 1987 | 3150 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2015 | 306 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2012 | 147 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2012 | 195 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2013 | 265 | 0.020 |
Why?
|
| Organisms, Genetically Modified | 1 | 2011 | 63 | 0.020 |
Why?
|
| Anticholesteremic Agents | 1 | 2019 | 967 | 0.020 |
Why?
|
| Telomere | 2 | 2008 | 940 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2001 | 9529 | 0.020 |
Why?
|
| Hydroxymethylbilane Synthase | 1 | 1990 | 6 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2010 | 2639 | 0.020 |
Why?
|
| Acetylation | 1 | 2014 | 1055 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1827 | 0.020 |
Why?
|
| Haplotypes | 1 | 2017 | 2713 | 0.020 |
Why?
|
| Dependovirus | 1 | 2016 | 712 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2012 | 532 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 1995 | 754 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2013 | 594 | 0.020 |
Why?
|
| Cattle | 2 | 2012 | 3841 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 520 | 0.020 |
Why?
|
| Genes, env | 1 | 1990 | 95 | 0.020 |
Why?
|
| Placenta | 1 | 2000 | 1709 | 0.020 |
Why?
|
| Synapses | 1 | 2020 | 1755 | 0.020 |
Why?
|
| Adult | 6 | 2014 | 220969 | 0.020 |
Why?
|
| Kinetics | 5 | 1999 | 6370 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2010 | 239 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2018 | 1389 | 0.020 |
Why?
|
| Swine | 1 | 2020 | 5907 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2012 | 350 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2015 | 2625 | 0.020 |
Why?
|
| CpG Islands | 1 | 2014 | 1192 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1993 | 1692 | 0.020 |
Why?
|
| Cartilage | 1 | 2014 | 806 | 0.020 |
Why?
|
| Cisplatin | 1 | 1996 | 1650 | 0.020 |
Why?
|
| Europe | 1 | 2016 | 3413 | 0.020 |
Why?
|
| Vesicular Transport Proteins | 1 | 2012 | 376 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 1990 | 262 | 0.020 |
Why?
|
| Adenine | 1 | 2015 | 985 | 0.020 |
Why?
|
| Indomethacin | 1 | 2010 | 323 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1996 | 1437 | 0.020 |
Why?
|
| Platelet Adhesiveness | 1 | 2009 | 154 | 0.020 |
Why?
|
| Reference Standards | 1 | 2013 | 1002 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 1993 | 571 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2011 | 880 | 0.020 |
Why?
|
| Bacteriophage lambda | 1 | 1989 | 142 | 0.020 |
Why?
|
| Age Factors | 2 | 2011 | 18381 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2012 | 635 | 0.020 |
Why?
|
| Rabbits | 1 | 1995 | 4770 | 0.020 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 542 | 0.020 |
Why?
|
| Lateral Line System | 1 | 2008 | 11 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 1991 | 749 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2160 | 0.020 |
Why?
|
| Disease Progression | 2 | 2019 | 13495 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2016 | 2326 | 0.020 |
Why?
|
| Cell Shape | 1 | 2009 | 369 | 0.020 |
Why?
|
| Neutropenia | 1 | 2014 | 885 | 0.020 |
Why?
|
| Agranulocytosis | 1 | 1988 | 97 | 0.020 |
Why?
|
| Primates | 1 | 2011 | 521 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 1926 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 1996 | 6188 | 0.020 |
Why?
|
| DNA Replication | 1 | 2015 | 1414 | 0.020 |
Why?
|
| Actins | 1 | 1995 | 2050 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 9277 | 0.020 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2007 | 39 | 0.020 |
Why?
|
| Glutathione | 1 | 2010 | 582 | 0.020 |
Why?
|
| Imidazoles | 1 | 2014 | 1175 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1990 | 1433 | 0.020 |
Why?
|
| Health Promotion | 1 | 2000 | 2206 | 0.020 |
Why?
|
| Ribonucleoprotein, U4-U6 Small Nuclear | 1 | 2007 | 13 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6762 | 0.020 |
Why?
|
| Transposases | 1 | 2007 | 104 | 0.020 |
Why?
|
| Biotechnology | 1 | 1989 | 281 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2010 | 370 | 0.020 |
Why?
|
| Cardiolipins | 1 | 1987 | 81 | 0.020 |
Why?
|
| RNA Probes | 2 | 2001 | 111 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2021 | 64568 | 0.020 |
Why?
|
| Enzyme Induction | 2 | 1999 | 452 | 0.020 |
Why?
|
| Deltaretrovirus | 1 | 1986 | 162 | 0.020 |
Why?
|
| Insulin | 1 | 2001 | 6593 | 0.020 |
Why?
|
| Haemophilus Infections | 1 | 1987 | 94 | 0.020 |
Why?
|
| Oocytes | 2 | 2005 | 1166 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2006 | 129 | 0.020 |
Why?
|
| Prostatitis | 1 | 1987 | 102 | 0.020 |
Why?
|
| Internet | 1 | 1999 | 3090 | 0.020 |
Why?
|
| Calpain | 1 | 2007 | 146 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 1987 | 397 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2008 | 242 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1597 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 1540 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2006 | 166 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1989 | 484 | 0.020 |
Why?
|
| Metabolomics | 1 | 2015 | 1656 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2005 | 87 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 2 | 2001 | 871 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 1852 | 0.020 |
Why?
|
| Hair Cells, Auditory | 1 | 2008 | 381 | 0.020 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2005 | 37 | 0.020 |
Why?
|
| G1 Phase | 2 | 1997 | 403 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 1901 | 0.020 |
Why?
|
| HIV Antibodies | 3 | 1986 | 1302 | 0.020 |
Why?
|
| Enteric Nervous System | 1 | 2008 | 213 | 0.020 |
Why?
|
| Infant | 2 | 2018 | 36152 | 0.020 |
Why?
|
| Hyperpigmentation | 1 | 2007 | 116 | 0.020 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2005 | 103 | 0.020 |
Why?
|
| Cytosol | 1 | 2008 | 886 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2007 | 982 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 2004 | 27 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1989 | 1131 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1990 | 687 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2700 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10548 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2006 | 261 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 4804 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 2005 | 297 | 0.010 |
Why?
|
| DNA Probes | 2 | 1999 | 541 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 4910 | 0.010 |
Why?
|
| Sarcomeres | 1 | 2007 | 368 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 1998 | 682 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1998 | 813 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2004 | 92 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 531 | 0.010 |
Why?
|
| Bicarbonates | 1 | 2005 | 292 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 2004 | 321 | 0.010 |
Why?
|
| Iron Overload | 1 | 2006 | 239 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 2005 | 400 | 0.010 |
Why?
|
| Tyrphostins | 1 | 2003 | 63 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2005 | 1058 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2004 | 174 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 860 | 0.010 |
Why?
|
| RNA Splicing | 2 | 1999 | 898 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2000 | 4668 | 0.010 |
Why?
|
| Sp3 Transcription Factor | 1 | 2002 | 27 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 614 | 0.010 |
Why?
|
| Leukemic Infiltration | 1 | 2003 | 47 | 0.010 |
Why?
|
| Ear | 1 | 2003 | 172 | 0.010 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2002 | 57 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 2004 | 393 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 876 | 0.010 |
Why?
|
| Chlorides | 1 | 2005 | 665 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2012 | 1894 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2001 | 26 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1988 | 1154 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 20074 | 0.010 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2004 | 305 | 0.010 |
Why?
|
| Olfactory Bulb | 1 | 2003 | 197 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinase 2 | 1 | 2001 | 9 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2001 | 102 | 0.010 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2001 | 10 | 0.010 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2001 | 14 | 0.010 |
Why?
|
| Wound Healing | 1 | 2012 | 2802 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2003 | 473 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 29868 | 0.010 |
Why?
|
| Motor Activity | 1 | 2011 | 2714 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2001 | 277 | 0.010 |
Why?
|
| Transcription Factor AP-2 | 1 | 2000 | 78 | 0.010 |
Why?
|
| Proteome | 1 | 2010 | 1857 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2003 | 512 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11736 | 0.010 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 416 | 0.010 |
Why?
|
| Receptor, Parathyroid Hormone, Type 2 | 1 | 1999 | 9 | 0.010 |
Why?
|
| Ictaluridae | 1 | 1999 | 8 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2000 | 168 | 0.010 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 1999 | 40 | 0.010 |
Why?
|
| Janus Kinase 1 | 1 | 1999 | 107 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 6403 | 0.010 |
Why?
|
| Arsenites | 1 | 1999 | 65 | 0.010 |
Why?
|
| Antibodies | 1 | 1987 | 2414 | 0.010 |
Why?
|
| Ionomycin | 1 | 1998 | 110 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41457 | 0.010 |
Why?
|
| Peripheral Nervous System | 1 | 1999 | 151 | 0.010 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 1999 | 327 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 1999 | 340 | 0.010 |
Why?
|
| Interleukin-3 | 2 | 1991 | 425 | 0.010 |
Why?
|
| Mortality | 1 | 2008 | 2899 | 0.010 |
Why?
|
| Calcium | 1 | 1990 | 5717 | 0.010 |
Why?
|
| Peptides | 1 | 1989 | 4354 | 0.010 |
Why?
|
| Chromosomes, Bacterial | 1 | 1998 | 280 | 0.010 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 1996 | 15 | 0.010 |
Why?
|
| Pyrroles | 1 | 2003 | 1125 | 0.010 |
Why?
|
| Genes, jun | 1 | 1996 | 69 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1989 | 4209 | 0.010 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1996 | 58 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1989 | 2527 | 0.010 |
Why?
|
| Antibody Diversity | 1 | 1996 | 72 | 0.010 |
Why?
|
| Retina | 1 | 2007 | 2655 | 0.010 |
Why?
|
| rac GTP-Binding Proteins | 1 | 1997 | 162 | 0.010 |
Why?
|
| Receptors, Thrombopoietin | 1 | 1998 | 160 | 0.010 |
Why?
|
| Codon, Initiator | 1 | 1996 | 50 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 1997 | 187 | 0.010 |
Why?
|
| Interphase | 1 | 1997 | 227 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 1996 | 29 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2000 | 711 | 0.010 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 1996 | 39 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 1999 | 560 | 0.010 |
Why?
|
| Chickens | 1 | 1998 | 858 | 0.010 |
Why?
|
| Homosexuality | 2 | 1987 | 267 | 0.010 |
Why?
|
| Anisomycin | 1 | 1995 | 27 | 0.010 |
Why?
|
| Choriocarcinoma | 1 | 1996 | 121 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 1998 | 516 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2008 | 10073 | 0.010 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1996 | 100 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 1997 | 740 | 0.010 |
Why?
|
| Algorithms | 1 | 2015 | 14018 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2006 | 4470 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 1996 | 451 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1992 | 5146 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1996 | 1141 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1996 | 535 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1989 | 11116 | 0.010 |
Why?
|
| Sphingosine | 1 | 1996 | 307 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1996 | 699 | 0.010 |
Why?
|
| Skin | 2 | 2000 | 4473 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 3680 | 0.010 |
Why?
|
| Drosophila | 1 | 2001 | 1494 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 2000 | 757 | 0.010 |
Why?
|
| Viscera | 1 | 1993 | 138 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 8998 | 0.010 |
Why?
|
| Collagen | 1 | 2001 | 2634 | 0.010 |
Why?
|
| Ethanol | 1 | 1999 | 1320 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1999 | 1988 | 0.010 |
Why?
|
| GATA4 Transcription Factor | 1 | 1993 | 124 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1996 | 1248 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 5110 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1999 | 1333 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 1992 | 224 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2000 | 5433 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1998 | 1798 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1995 | 1185 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1997 | 2200 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1991 | 561 | 0.010 |
Why?
|
| Immune Sera | 1 | 1990 | 605 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 1301 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1992 | 1605 | 0.000 |
Why?
|
| Oxidative Stress | 1 | 1999 | 3113 | 0.000 |
Why?
|
| Brain | 1 | 1994 | 27101 | 0.000 |
Why?
|
| Endothelin-1 | 1 | 1989 | 302 | 0.000 |
Why?
|
| Middle Aged | 2 | 2013 | 220584 | 0.000 |
Why?
|
| Endocytosis | 1 | 1991 | 955 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 36402 | 0.000 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1987 | 225 | 0.000 |
Why?
|
| Blood Coagulation Disorders | 1 | 1989 | 350 | 0.000 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 1986 | 104 | 0.000 |
Why?
|
| Child | 1 | 2014 | 80079 | 0.000 |
Why?
|
| HIV Seropositivity | 1 | 1989 | 959 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1998 | 14648 | 0.000 |
Why?
|
| HIV Infections | 1 | 1989 | 17337 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1987 | 1526 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1983 | 2088 | 0.000 |
Why?
|
| Aged | 1 | 2013 | 169042 | 0.000 |
Why?
|
| Biological Assay | 1 | 1983 | 626 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1987 | 4533 | 0.000 |
Why?
|
| Risk | 1 | 1986 | 9604 | 0.000 |
Why?
|